tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c
Michael C. Wei(The Royal Melbourne Hospital), Stanley J. Korsmeyer(Howard Hughes Medical Institute)
Cited by 1,253
Related Papers
Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death
|Journal of Biological Chemistry|1999|1.1k
Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes
|Cell|1981|939
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
|The Lancet Oncology|2022|429
Solution Structure of the Proapoptotic Molecule BID
|Cell|1999|391